Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multi-center Inpatient Cirrhosis Cohort Jasmohan S Bajaj et al.…
Update on the management of gastrointestinal varices Umesha Boregowda et al. Abstract Cirrhosis of liver is a major problem in…
Baveno VII – Renewing consensus in portal hypertension Roberto de Franchis et al. Summary To expand on the work of…
Hepatic encephalopathy: Thinking Beyond ammonia Hanna Blaney, M.D., M.P.H.,* and Sharon DeMorrow, Ph.D Hepatic encephalopathy (HE) is a syndrome of…
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis Elisa Pose et al. ABSTRACT…
Rifaximin-a reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial Vishal C. Patel et al.…
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease Fasiha Kanwal et al.…
Burden of compensated and decompensated cirrhosis: real world data from an Italian population-based cohort study S Cammarota et al. Abstract…
Anti-Diabetic Medications for Type 2 Diabetics with Non-Alcoholic Fatty Liver Disease. Evidence from a Network Meta-Analysis of Randomised Controlled Trials…
Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis Samuel Anthony Lachlan Hall et al. Abstract Background and…
Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020) Philipp K. Haber et al. Background…
Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment Ramzi Hassouneh and Jasmohan S.…
Diagnosis and Treatment of Alcohol-Associated Liver Disease A Review Ashwani K. Singal, MD; Philippe Mathurin, MD IMPORTANCE Alcohol-associated liver disease…
The Use of Rifaximin in Patients With Cirrhosis Paolo Caraceni et al. Abstract Rifaximin is an oral nonsystemic antibiotic with…
Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis Fen Liu et al. Abstract Background and Aim Previous…
Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients with Cirrhosis Amirhossein Shamsaddin et al. Abstract Background and aims…
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome Florence Wong, M.B., B.S., M.D., et al for the…
Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American…
Real-world experience with obeticholic acid in patients with primary biliary cholangitis Daphne D’Amato et al.Italian PBC Registry and the Club…
Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and…
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome Florence Wong, et al. Abstract BACKGROUND The vasoconstrictor terlipressin…
The Global Incidence of Faecal Microbiota Transplantation-related Adverse Events From 2000 to 2020 Cicilia Marcella et al. Abstract Background: Faecal microbiota…
The intestinal barrier, an arbitrator turned provocateur in IBD Mehandru S, and Colombel JF Key studies published in 2020 demonstrate…
CLINICAL PRACTICE GUIDELINES AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders Grace L.…